| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |